Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- F-4 Registration of securities (foreign)
- 3.1 EX-3.1
- 4.1 EX-4.1
- 4.2 EX-4.2
- 5.1 EX-5.1
- 8.1 EX-8.1
- 10.1 EX-10.1
- 10.2 EX-10.2
- 10.3 EX-10.3
- 10.4 EX-10.4
- 10.5 EX-10.5
- 10.6 EX-10.6
- 10.6.1 EX-10.6.1
- 10.7 EX-10.7
- 10.8 EX-10.8
- 10.9 EX-10.9
- 10.10 EX-10.10
- 10.11 EX-10.11
- 10.12 EX-10.12
- 10.13 EX-10.13
- 10.14 EX-10.14
- 10.15 EX-10.15
- 10.16 EX-10.16
- 10.17 EX-10.17
- 10.18 EX-10.18
- 10.19 EX-10.19
- 10.20 EX-10.20
- 10.20.1 EX-10.20.1
- 10.20.2 EX-10.20.2
- 10.20.3 EX-10.20.3
- 10.21 EX-10.21
- 10.21.1 EX-10.21.1
- 10.21.2 EX-10.21.2
- 10.22 EX-10.22
- 10.22.1 EX-10.22.1
- 10.22.2 EX-10.22.2
- 10.23 EX-10.23
- 10.24 EX-10.24
- 10.25 EX-10.25
- 10.26 EX-10.26
- 10.27 EX-10.27
- 22.1 EX-22.1
- 23.1 EX-23.1
- 23.2 EX-23.2
- 23.4 EX-23.4
- 99.1 EX-99.1
- 99.2 EX-99.2
- 99.3 EX-99.3
- 99.4 EX-99.4
MREO similar filings
Filing view
External links
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated March 8, 2018, with respect to the financial statements of OncoMed Pharmaceuticals, Inc. incorporated by reference in the Registration Statement (FormF-4) and related Proxy/Prospectus of Mereo BioPharma Group plc for the registration of shares of its common stock.
/s/ Ernst & Young LLP |
Redwood City, California |
January 24, 2019 |